- Home
- MRNA vs PKX Comparison
MRNA vs PKX Comparison
Compare MRNA & PKX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- PKX
- Stock Information
- Founded
- MRNA 2010
- PKX 1968
- Country
- MRNA United States
- PKX South Korea
- Employees
- MRNA N/A
- PKX N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- PKX Steel/Iron Ore
- Sector
- MRNA Health Care
- PKX Industrials
- Exchange
- MRNA Nasdaq
- PKX Nasdaq
- Market Cap
- MRNA 10.6B
- PKX 14.0B
- IPO Year
- MRNA 2018
- PKX 1994
- Fundamental
- Price
- MRNA $24.68
- PKX $46.26
- Analyst Decision
- MRNA Hold
- PKX
- Analyst Count
- MRNA 20
- PKX 0
- Target Price
- MRNA $51.94
- PKX N/A
- AVG Volume (30 Days)
- MRNA 8.6M
- PKX 253.8K
- Earning Date
- MRNA 05-01-2025
- PKX 04-24-2025
- Dividend Yield
- MRNA N/A
- PKX 2.28%
- EPS Growth
- MRNA N/A
- PKX N/A
- EPS
- MRNA N/A
- PKX 7.18
- Revenue
- MRNA $3,177,000,000.00
- PKX $48,940,474,950.00
- Revenue This Year
- MRNA N/A
- PKX $2.23
- Revenue Next Year
- MRNA $22.14
- PKX $3.60
- P/E Ratio
- MRNA N/A
- PKX $25.83
- Revenue Growth
- MRNA N/A
- PKX N/A
- 52 Week Low
- MRNA $23.15
- PKX $39.40
- 52 Week High
- MRNA $170.47
- PKX $75.30
- Technical
- Relative Strength Index (RSI)
- MRNA 42.25
- PKX 49.30
- Support Level
- MRNA $23.70
- PKX $46.10
- Resistance Level
- MRNA $28.52
- PKX $46.93
- Average True Range (ATR)
- MRNA 1.34
- PKX 0.79
- MACD
- MRNA -0.03
- PKX 0.23
- Stochastic Oscillator
- MRNA 29.80
- PKX 70.70
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About PKX POSCO Holdings Inc.
POSCO Holdings Inc is a holding company and operates through its subsidiaries. The company operates across four distinct segments. The first segment is the Steel Segment, which includes the production and sale of steel products. The second segment is the Green Infrastructure Business, which is further divided into three operations. The Trading Segment comprises trading and natural resource development activities. The Construction Segment involves the planning, designing, and construction of industrial plants, civil engineering projects, and buildings. The Energy and Other Segments include power generation, as well as information technology and operational technology services. The third segment is the Green Materials and Energy Segment, and the fourth segment is the Others Segment.